- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02812537
Clinical and Social Trajectories of Children and Adolescents With Disruptive Behavior (TRAJECTORIES)
Clinical and Social Trajectories of Children and Adolescents With Disruptive Behavior: Multidisciplinary Approach of Pediatric and Psychiatric Emergencies in the Rhône-Alpes Auvergne Region
Conduct disorders are defined as "repetitive and persistent pattern of behavior in which the basic rights of others or major age-appropriate norms are violated". So defined, these disorders are at the crossroads of psychiatry, social field and justice. Conduct disorder management is a public health issue and a societal question. Conduct disorders affect 5 to 9% of 15-year old boys.
Care management of children and adolescents admitted for disruptive behaviors in emergency rooms is an issue. No consensus or official recommendation exists. However, use of emergency care in this context is increasing in most western countries and it exposes to several risks (inappropriate use of hospitalizations, social rupture, ignorance of comorbidities and suicide risk). The Trajectories project is designed to describe children and adolescents with disruptive behaviors, their care management and to follow their life trajectory and psychiatric evolution after admission to emergency rooms. Better understanding this population will improve their medical and social care management, thereby giving professionals the right tools.
The main objective of this project is to implement a multidisciplinary and integrative research combining clinical considerations and social sciences to determine the "trajectory" of this population.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Yannis Gansel, MD
- Phone Number: +33 472129562
- Email: yannis.gansel@chu-lyon.fr
Study Locations
-
-
-
Bron, France, 69677
- Recruiting
- Hospices Civils de Lyon
-
Contact:
- Yannis Gansel, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Children and adolescents less than 16 years old
- Children and adolescents admitted to emergency rooms for aggressiveness, violence, fugue or theft
Exclusion Criteria:
- Children and adolescents admitted to emergency rooms for a reason not directly link with aggressiveness, violence, fugue or theft
- Opposition to the subject or the family to participate to this research
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
patients with conduct disorders
Girls and boys having less than 16 years old and admitted to emergency room for aggressiveness, violence, fugue or theft.
|
interview with a specialist
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of new admissions to emergency rooms for aggressiveness, violence, fugue or theft
Time Frame: 6 months
|
Six months follow-up of these children and adolescents in their future trajectory after the first admission to emergency room for disruptive behavior
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Age of the children and adolescents admitted to emergency rooms for aggressiveness, violence, fugue or theft
Time Frame: Day 0
|
mean age
|
Day 0
|
Gender of the children and adolescents admitted to emergency rooms for aggressiveness, violence, fugue or theft
Time Frame: Day 0
|
Day 0
|
|
Number of children and adolescents precisely diagnosed with " behavior/conduct disorder
Time Frame: Day 0
|
Day 0
|
|
Number of hospitalization
Time Frame: Day 0
|
following the admission
|
Day 0
|
number of patients admitted to emergency rooms for aggressiveness
Time Frame: Day 0
|
Day 0
|
|
number of patients admitted to emergency rooms for violence
Time Frame: Day 0
|
Day 0
|
|
number of patients admitted to emergency rooms for fugue
Time Frame: Day 0
|
Day 0
|
|
number of patients admitted to emergency rooms for theft
Time Frame: Day 0
|
Day 0
|
|
number of suicide attempts
Time Frame: 24 months
|
24 months
|
|
number of patients with disruptive behavior recurrence
Time Frame: 24 months
|
24 months
|
|
evolution of the CBCL score
Time Frame: 24 months
|
24 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Yannis Gansel, MD, Hospices Cicils de Lyon
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 69HCL16_0136
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Disruptive Behavior Disorder
-
Washington University School of MedicineRecruitingDisruptive Behavior DisorderUnited States
-
IWK Health CentreCanadian Institutes of Health Research (CIHR)CompletedDisruptive Behavior DisorderFinland
-
Christina StudtsUniversity of VermontCompletedParenting | Disruptive Behavior DisorderUnited States
-
Centre for Addiction and Mental HealthOntario Mental Health FoundationCompletedDisruptive Behavior DisorderCanada
-
IRCCS Fondazione Stella MarisUniversity of PisaCompletedAttention Deficit and Disruptive Behavior Disorders | Oppositional Defiant Disorder | Disruptive Behavior DisorderItaly
-
University of Illinois at ChicagoNational Institute of Mental Health (NIMH)RecruitingExecutive Function | Disruptive Behavior | Disruptive Behavior Disorder, Childhood OnsetUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
IWK Health CentreCanadian Institutes of Health Research (CIHR)CompletedPediatric Disruptive Behaviour DisorderCanada
-
Janssen Pharmaceutica N.V., BelgiumCompletedConduct Disorder | Oppositional Defiant Disorder | Disruptive Behavior Disorder
-
Janssen Pharmaceutica N.V., BelgiumCompletedConduct Disorder | Oppositional Defiant Disorder | Disruptive Behavior Disorder
Clinical Trials on patients with conduct disorders
-
Mayo ClinicRecruitingPlasma Cell DisordersUnited States
-
Beijing HuiLongGuan HospitalCompletedSchizophrenia | Major Depressive DisorderChina
-
Centre Hospitalier Universitaire, AmiensWithdrawn
-
Federico II UniversityCompleted
-
University of British ColumbiaCompletedHematological Malignancy | Bone Marrow Failure SyndromeCanada
-
University of ChicagoRecruiting
-
University of ValenciaUniversitat Jaume IRecruiting
-
National Taiwan University HospitalNot yet recruitingEducation, MedicalTaiwan
-
University of GuelphCentre for Addiction and Mental Health; Canadian Institutes of Health Research...RecruitingDepressive Disorder | Mood Disorders | Anxiety Disorders | Trauma and Stressor Related Disorders | Conduct Disorder | Oppositional Defiant Disorder | Child Behavior Disorders | Regulation, EmotionCanada
-
Hamid Al-Essa Organ Transplant CenterCompletedCOVID-19 Positive Patients With Acute Kidney InjuryKuwait